Papatheodoridis, G. V. Et Al. 2015. Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir. JOURNAL OF HEPATOLOGY , vol.62, no.2 , 363-370.

Papatheodoridis, G. V., Dalekos, G. N., Yurdaydin, C., Buti, M., Goulis, J., Arends, P., ... Sypsa, V.(2015). Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir. JOURNAL OF HEPATOLOGY , vol.62, no.2, 363-370.

Papatheodoridis, ONUR Et Al. "Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir," JOURNAL OF HEPATOLOGY , vol.62, no.2, 363-370, 2015

Papatheodoridis, ONUR Et Al. "Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir." JOURNAL OF HEPATOLOGY , vol.62, no.2, pp.363-370, 2015

Papatheodoridis, G. V. Et Al. (2015) . "Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir." JOURNAL OF HEPATOLOGY , vol.62, no.2, pp.363-370.

@article{article, author={ONUR KESKİN Et Al. }, title={Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir}, journal={JOURNAL OF HEPATOLOGY}, year=2015, pages={363-370} }